PLAY > New Plays	Tuesday, May 29, 2001

	New Split Plays   New Candidate Plays   New Momentum Plays
(We update our stop losses daily at the CURRENT PLAYS page.)

New Split Plays

None

New Candidate Plays

CIMA - Cima Labs Inc. $76.95 +2.15

Cima Labs has been steadily forging ahead since 4/27/01, when it announced the U.S. launch by AstraZeneca (NYSE:AZN) of its Zomig-ZMT orally disintegrating migraine headache compound. Cima specializes in producing products for pharmaceutical companies that are based upon its OralSolv and Durasolv drug delivery systems. This enables patients to ingest drugs through fast dissolving technologies without the use of water and without any adverse tastes. Turning to CIMA's chart, we see that the stock has just broken out of a seven-month base pattern. Today's strong advance was a new closing high for the stock and judging by the width of CIMA's base, the price target on CIMA becomes $107. Traders wishing to initiate positions in CIMA could look to do so on an advance above today's high of $75.35 on volume of at least 300,000 shares. We need volume to come in strong to confirm CIMA's strength. Speaking of volume, we issue one caveat regarding CIMA: volume can be weak at times, which adds to the biotech stock's volatility. Therefore, this is an aggressive play that might call for half positions. Our initial stops are set at $67.95 to protect against a turnaround.

Picked on May 29th @ $76.95 Change Since Picked 0.00 Stop Loss @ $67.95
Interactive Chart	Quote	News	First Call on CIMA

New Momentum Plays

None

New Plays Index